Stock screenerAll disclosures → EDGAR →
ERNA
Conviction 62HealthcareScan · Mon, Jul 20, 2026ERNA$5.45-15.11%
ResistanceSupportVol 14Vol MA14 1.92M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price5.45
Change-15.11%
Gap-2.34%
Rel volume0.01×
Avg volume1.36M
Avg $ vol9.16M
SMA 206.35
SMA 508.01
SMA 2002.72
Price vs 50-31.92%
Price vs 200+100.21%
MA stackmixed
50/200 cross—
Supertrenddown · 8.01
RSI (14)42
MACD hist0.02
MACD crossbull · 3d
Stoch %K / %D1 / 21
ADX (14)19
+DI / −DI33 / 22
RSI divergence—
MACD divergenceBullish
ATR %+18.49%
ADR %13.46%
52w high13.63
52w low0.1476
From 52w high-60.01%
Above 52w low+3592.41%
New 52w highNo
SqueezeOn · 12d
Bollinger width32.66%
%B0.06
Donchian pos6.10%
Donchian high9.90
Donchian low5.16
AVWAP (52w high)9.50
vs AVWAP high-42.63%
AVWAP (52w low)7.46
vs AVWAP low-26.99%
OBV trendUp
Chaikin MF (20)-0.65
Today vs 20d0.01×
Avg vol (14d)1.92M
Avg vol (20d)1.36M
Avg $ vol (20d)9.16M
Market cap6.36M
RS 3m (vs SPY)+3152.95%
RS 6m (vs SPY)+397.84%
RS line new highNo
Trend template6/8
Technical rank63.2
1 week-1.62%
1 month-7.47%
3 months+2522.71%
6 months+361.86%
1 year+167.16%
YTD+369.83%
P/E-0.45
P/B0.93
P/S1.10
P/FCF-0.90
EPS-2.24
Div yield—
ROE-205.34%
ROA-133.59%
Debt/Eq0.30
Current2.89
EV/EBITDA-0.44
Gross margin8.38%
Net margin-242.83%
Rev growth-70.72%
EPS growth68.38%
Price target30.00
Target upside450.46%
Analyst ratingBuy
Institutional12.38%
Ent. value4.07M
Revenue1.48M
Net income-5.51M
Gross profit547K
Free cash flow-7.05M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out1.17M
Employees5
ListedFri, Mar 26, 2021
Free float13.66M
Float %46.9%
Short interest29.38K
Days to cover0.4d
Short volume25.8%
Squeeze score3 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$6.95
Last surprise—
Setup gradeB
Conviction62 / 100
Pattern quality—
Tech rank63.2 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance8.92
Support5.33
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ERNA
No recent disclosed trades by Congress in ERNA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ERNA
No recent insider (Form 4) filings in ERNA. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in ERNA · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.